Analysis of the Effects of the Osteopathic Manipulative Treatment in Carriers of Temporomandibular Disorders
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02974166 |
Recruitment Status :
Completed
First Posted : November 28, 2016
Last Update Posted : November 28, 2016
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Temporomandibular Disorder | Other: Conventional Group Other: Osteopathic Group Drug: Ibuprofen Drug: Cyclobenzaprine Hydrochloride | Not Applicable |
A standardized TMD examination was executed in all patients by a dentist following the Research Diagnostic Criteria for Temporomandibular Disorders (RDC/ TMD) questionnaire, Axis I and II, portuguese version. The RDC/ TMD is compound by a 31 items questionnaire and a ten items clinical exam. All these items are related to patients symptoms and signs; to mandibular functional impairment; and social-demographics, social-economics, psychological e psychosocial data. The first part as Axis I tend to clinical assess and classify the TMD and the second, as Axis II propose a chronic pain score that could quantify the psychosocial impairment and present a subjects profile.
Others assessment instruments utilized on the research were the VAS consists in a 10 cm horizontal line with "no pain" on the left side and "worst pain" on right side, then the subjects were instructed to vertical risk the level of pain. The digital caliper with a 0,03 mm precision was used to measure the maximal mouth opening (MMO) as the maximal inter-incisal vertical distance of the incisors. The subjects were seated at 90° with neutral head position and solicited to open their mouths the maximum they can unassisted and without pain, maximum unassisted opening and maximum assisted opening. Also, a portable digital pressure algometer for measuring sensitivity to pressure before it became painful. The masseters and temporalis muscles trigger point location were used as reference to guarantee the reproducibility of the proceeding as well as to assess the always the same site. The statistical analysis was performed using the means comparisons for the parametric tests through Student T test and for the non-parametrical data, Wilcoxon. Also, it was made the descriptive statistical with frequencies analysis.
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 32 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Single (Investigator) |
Primary Purpose: | Treatment |
Official Title: | Analysis of the Effects of the Osteopathic Manipulative Treatment in Carriers of Temporomandibular Disorders: Randomized Clinical Trial |
Study Start Date : | March 2012 |
Actual Primary Completion Date : | November 2015 |
Actual Study Completion Date : | August 2016 |

Arm | Intervention/treatment |
---|---|
Active Comparator: Conventional Group
Individuals with temporomandibular disorder were used rigid occlusal splints and medication (Ibuprofen and Cyclobenzaprine Hydrochloride) under the dentist professor supervision. Likewise, speech therapists performed assessments, measurements, massages, stretches and therapeutic exercises for head, neck and mouth regions during four weeks.
|
Other: Conventional Group
Rigid occlusal splints and medication (Ibuprofen and Cyclobenzaprine Hydrochloride) were made and prescribed under the dentist professor supervision. Likewise, speech therapists performed assessments, measurements, massages, stretches and therapeutic exercises for head, neck and mouth regions. Drug: Ibuprofen The medication was prescribed by the dentist as nonsteroidal anti-inflammatory drug if necessary.
Other Name: anti-inflammatory drug Drug: Cyclobenzaprine Hydrochloride The medication was prescribed by the dentist as muscle relaxer if necessary.
Other Name: muscle relaxer |
Experimental: Osteopathic Group
Individuals with temporomandibular disorder received the same assistance of Conventional Group, cited above, plus the osteopathic care during 20 to 30 minutes once a week until the end of dental and speech therapy treatments (4 weeks).
|
Other: Osteopathic Group
Same assistance of Conventional Group, cited above, plus the osteopathic care during 20 to 30 minutes once a week during four weeks. The osteopathic treatment consisted in an individualized assessment of mobility restrictions of myofascial tissues and joints and the application of smooth techniques such myofascial release, membranous strain and counterstrain, muscle energy, cranial and high velocity and low amplitude. Drug: Ibuprofen The medication was prescribed by the dentist as nonsteroidal anti-inflammatory drug if necessary.
Other Name: anti-inflammatory drug Drug: Cyclobenzaprine Hydrochloride The medication was prescribed by the dentist as muscle relaxer if necessary.
Other Name: muscle relaxer |
- Pain intensity [ Time Frame: 4 weeks ]Pain assessed by visual analogue scale.
- (RDC/ TMD) Research Diagnostic Criteria for Temporomandibular Disorders [ Time Frame: 4 weeks ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 60 Years (Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- subjects of both genders with TMD diagnosed and minimum pain intensity of 40 mm on a visual analogue scale (VAS) who need dental treatment.
Exclusion Criteria:
- continuous use of analgesic medication, mouth opening above 40 mm, presence of any other orofacial pain not related to TMD and being under orthodontic or TMD treatment.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02974166
Brazil | |
Brazilian Institute of Osteopathy | |
Porto Alegre, Rio Grande do Sul, Brazil |
Principal Investigator: | Thiago B Susin | IBO |
Responsible Party: | Thiago Boeira Susin, PT, DO, PT, DO, Instituto Brasileiro de Osteopatia |
ClinicalTrials.gov Identifier: | NCT02974166 History of Changes |
Other Study ID Numbers: |
InstitutoBOsteopatia |
First Posted: | November 28, 2016 Key Record Dates |
Last Update Posted: | November 28, 2016 |
Last Verified: | November 2016 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Keywords provided by Thiago Boeira Susin, PT, DO, Instituto Brasileiro de Osteopatia:
Temporomandibular Disorder Osteopathic Manipulative Treatment Rigid Splint Speech Therapy |
Additional relevant MeSH terms:
Disease Temporomandibular Joint Disorders Temporomandibular Joint Dysfunction Syndrome Pathologic Processes Craniomandibular Disorders Mandibular Diseases Jaw Diseases Musculoskeletal Diseases Joint Diseases Muscular Diseases Stomatognathic Diseases Myofascial Pain Syndromes Ibuprofen Amitriptyline Anti-Inflammatory Agents |
Cyclobenzaprine Anti-Inflammatory Agents, Non-Steroidal Analgesics, Non-Narcotic Analgesics Sensory System Agents Peripheral Nervous System Agents Physiological Effects of Drugs Antirheumatic Agents Cyclooxygenase Inhibitors Enzyme Inhibitors Molecular Mechanisms of Pharmacological Action Antidepressive Agents, Tricyclic Antidepressive Agents Psychotropic Drugs Muscle Relaxants, Central |